Search
Inmode Ltd
INMDAdd to Watchlist
14.800USD
+0.120+0.82%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
937.71MMarket Cap
10.81P/E TTM
More Details of Inmode Ltd Company
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Inmode Ltd Info
Ticker SymbolINMD
Company nameInmode Ltd
IPO dateAug 08, 2019
CEOMizrahy (Moshe)
Number of employees599
Security typeOrdinary Share
Fiscal year-endAug 08
AddressTavor Building, Sha'ar Yokneam
CityYOKNEAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code2069200
Phone97249097470
Websitehttps://inmodemd.com/
Ticker SymbolINMD
IPO dateAug 08, 2019
CEOMizrahy (Moshe)
Company Executives of Inmode Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Moshe Mizrahy
Mr. Moshe Mizrahy
Chief Executive Officer
Chief Executive Officer
4.30M
--
Dr. Michael Kreindel
Dr. Michael Kreindel
Chief Technology Officer, Director
Chief Technology Officer, Director
3.11M
--
Mr. Yair Malca
Mr. Yair Malca
Chief Financial Officer
Chief Financial Officer
71.14K
+29.37%
Dr. Hadar Ron, M.D.
Dr. Hadar Ron, M.D.
Independent Director
Independent Director
55.27K
-7.24%
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Miri Segal-Scharia
Ms. Miri Segal-Scharia
CEO - MS IR LLC
CEO - MS IR LLC
--
--
Mr. Nadav Kenneth
Mr. Nadav Kenneth
Independent Director
Independent Director
--
-100.00%
Mr. Brandon Nye
Mr. Brandon Nye
Vice President - Sales of West US
Vice President - Sales of West US
--
--
Mr. Michael Dennison
Mr. Michael Dennison
President, North America
President, North America
--
--
Mr. Matt Rodgers
Mr. Matt Rodgers
Vice President - Sales of Canada
Vice President - Sales of Canada
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Moshe Mizrahy
Mr. Moshe Mizrahy
Chief Executive Officer
Chief Executive Officer
4.30M
--
Dr. Michael Kreindel
Dr. Michael Kreindel
Chief Technology Officer, Director
Chief Technology Officer, Director
3.11M
--
Mr. Yair Malca
Mr. Yair Malca
Chief Financial Officer
Chief Financial Officer
71.14K
+29.37%
Dr. Hadar Ron, M.D.
Dr. Hadar Ron, M.D.
Independent Director
Independent Director
55.27K
-7.24%
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Miri Segal-Scharia
Ms. Miri Segal-Scharia
CEO - MS IR LLC
CEO - MS IR LLC
--
--
FAQs
Who are the top five shareholders of Inmode Ltd?
The top five shareholders of Inmode Ltd are: Mr. Moshe Mizrahy
How many institutions hold shares of Inmode Ltd (INMD)?
As of 2026Q1, 582 institutions hold shares of Inmode Ltd, with a combined market value of approximately 33.96M, accounting for 53.60% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -18464721.00.